Two Sigma Securities’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Two Sigma Securities’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-772	Closed	-$19.9K	–	2172
2024 Q4	$19.9K	Buy	+772	New	+$17K	﹤0.01%	1323
2024 Q3	–	Sell	-72	Closed	-$4.35K	–	3601
2024 Q2	$4.35K	Sell	72 -29	-29%	-$1.84K	﹤0.01%	2864
2024 Q1	$6.31K	Buy	+101	New	+$11.3K	﹤0.01%	2815

Other funds holding SXTP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SHF

Safe Harbor Fiduciary Pensacola, Florida $105M AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's SXTP Position: Q1 2025 in Review

Two Sigma Securities sold out of 60 Degrees Pharmaceuticals (SXTP) in Q1 2025, closing a stake of 772 shares — an estimated $19.9K sold.

Two Sigma Securities first reported a position in SXTP in Q1 2024 and held it in 3 quarters. The position peaked at $19.9K in Q4 2024. 6 funds tracked by Wall St. Rank hold SXTP as of Q1 2025.

Two Sigma Securities reported no remaining 60 Degrees Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 772 60 Degrees Pharmaceuticals shares in Q1 2025, an estimated $19.9K.
Two Sigma Securities first reported a position in 60 Degrees Pharmaceuticals in Q1 2024 and held it in 3 quarters.
Two Sigma Securities's 60 Degrees Pharmaceuticals position peaked at $19.9K in Q4 2024.
6 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.